Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$883.2 - $1071.19 $3.44 Million - $4.18 Million
-3,900 Reduced 70.91%
1,600 $1.68 Million
Q1 2024

May 08, 2024

SELL
$902.69 - $993.35 $3.25 Million - $3.58 Million
-3,600 Reduced 39.56%
5,500 $5.29 Million
Q4 2023

Feb 02, 2024

BUY
$775.18 - $881.7 $3.88 Million - $4.41 Million
5,000 Added 121.95%
9,100 $7.99 Million
Q3 2023

Oct 26, 2023

BUY
$692.45 - $844.37 $830,940 - $1.01 Million
1,200 Added 41.38%
4,100 $3.37 Million
Q2 2023

Aug 08, 2023

BUY
$700.03 - $830.35 $70,003 - $83,035
100 Added 3.57%
2,900 $2.08 Million
Q1 2023

May 02, 2023

BUY
$680.49 - $826.97 $476,343 - $578,879
700 Added 33.33%
2,800 $2.3 Million
Q4 2022

Jan 23, 2023

BUY
$705.89 - $766.39 $1.48 Million - $1.61 Million
2,100 New
2,100 $0
Q3 2019

Oct 03, 2019

SELL
$273.46 - $318.39 $1.12 Million - $1.31 Million
-4,100 Closed
0 $0
Q2 2019

Jul 10, 2019

BUY
$299.6 - $414.82 $1.23 Million - $1.7 Million
4,100 New
4,100 $255,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Xr Securities LLC Portfolio

Follow Xr Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xr Securities LLC with notifications on news.